Bangladesh Medical University
Also known as: Bangabandhu Sheikh Mujib Medical University, Bangladesh | Bangabandhu Sheikh Mujib Medical University (BSMMU) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | bangabandhu sheikh mujib medical unuversity | Bangladesh Medical University | Bngabandhu Sheikh Mujib Medical University | BSMMU | BSMMU, Bangladesh | BSMMU (Recruiting) | BSMMU(Recruiting), Dhaka, Bangladesh, 1000 | BSMMU(Recruting), Dhaka-1000, Bangladesh | BSMMU, Shahbagh, Dhaka, Bangladesh | Department of Pharmacology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. | Dr. Mohammad Mamun Khan | Farzana Khan Shoma | Professor and Chairman of Pharmacology, BSMMU | Resident doctor, BSMMU | Resident, phase-B
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2009Last known activity
Oct 1, 2025
Timeline
1960s
- Jan 1, 1965
Bangladesh Medical University— Founded
Drugs by trial phase (121 distinct, 131 trials)
Phase 4 (33 own, 0 via acquisition)
Phase 3 (18 own, 0 via acquisition)
Phase 2 (45 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Indications
Studied for
- Arsenic Poisoning
- Arthritis
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Asthma
- Autism Spectrum Disorder
- Bowen's Disease
- Carcinoma
- Carcinoma, Hepatocellular
- Cataract
- Communicable Diseases
- Convalescence
- Dyslipidemias
- Head and Neck Neoplasms
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Hyperlipidemias
- Hyperlipoproteinemias
- Hyperplasia
- Infections
- Keratosis
- Keratosis, Actinic
- Leukemia
- Leukemia, Lymphoid
- Lung Diseases
- Lung Diseases, Obstructive
- Lupus Nephritis
- Nephritis
- Neurotoxicity Syndromes
- Peripheral Nervous System Diseases
- Poisoning
- Postoperative Pain
- Postpartum Hemorrhage
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prostatic Hyperplasia
- Pulmonary Disease, Chronic Obstructive
- Spondylarthritis
- Squamous Cell Carcinoma of Head and Neck
- Undifferentiated Connective Tissue Diseases
- Urinary Bladder, Overactive
- Urinary Tract Infections
Recent trials (50)
- NCT07252518Lead sponsorN/AOct 1, 2025
- NCT07252518CollaboratorN/AOct 1, 2025
- NCT07252518Sponsor investigatorN/AOct 1, 2025
- NCT07252518OfficialN/AOct 1, 2025
- NCT07266259Sponsor investigatorN/ASep 19, 2025
- NCT07266259OfficialN/ASep 19, 2025
- NCT07266259Lead sponsorN/ASep 19, 2025
- NCT07185802Sponsor investigatorN/AAug 27, 2025
- NCT07185802Lead sponsorN/AAug 27, 2025
- NCT07185802OfficialN/AAug 27, 2025
- NCT07085598Lead sponsorN/AJul 31, 2025
- NCT07084597Sponsor investigatorN/AJul 31, 2025
- NCT07084597Lead sponsorN/AJul 31, 2025
- NCT07085598Sponsor investigatorN/AJul 31, 2025
- NCT07161336OfficialPhase 2Jul 30, 2025
Details
- Founded
- Dhaka, BD Jan 1, 1965
- Last known activity
- Oct 1, 2025